Alzheimer’s disease drug Leqembi will be covered by Medicare once the Food and Drug Administration grants traditional approval, which could come as soon as early July.
Alzheimer’s Drug Market To Hit $13 Billion As FDA Approvals And Insurance Coverage Escalate
